首页分子通2-(3-{[[2-(4-cyano-phenoxy)-benzyl]-((S)-1-dimethylaminomethyl-3,3-dimethyl-butyl)-amino]-methyl}-benzyl)-1,1-dioxo-1λ6-isothiazolidine-3-carboxylic acid ((1S,2S,3S,5R)-2,6,6-trimethyl-bicyclo[3.1.1]hept-3-yl)-amide trifluoroacetate salt
2-(3-{[[2-(4-cyano-phenoxy)-benzyl]-((S)-1-dimethylaminomethyl-3,3-dimethyl-butyl)-amino]-methyl}-benzyl)-1,1-dioxo-1λ6-isothiazolidine-3-carboxylic acid ((1S,2S,3S,5R)-2,6,6-trimethyl-bicyclo[3.1.1]hept-3-yl)-amide trifluoroacetate salt | 1308661-73-5
2-(3-{[[2-(4-cyano-phenoxy)-benzyl]-((S)-1-dimethylaminomethyl-3,3-dimethyl-butyl)-amino]-methyl}-benzyl)-1,1-dioxo-1λ6-isothiazolidine-3-carboxylic acid ((1S,2S,3S,5R)-2,6,6-trimethyl-bicyclo[3.1.1]hept-3-yl)-amide trifluoroacetate salt
The present invention relates to compounds according to formula 1,
which exhibit cytotoxic activity. The compounds may be used in the treatment of cancer.